Receptors Of Plasmacytoid Dendritic Cells And Their Ligands

浆细胞样树突状细胞受体及其配体

• 批准号: 7906750
• 负责人: Wei Cao
• 金额: $ 37.39万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-08-01 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7906750
• 关键词: Antigens; Autoimmune Diseases; Biochemical; Biological Process; Blood; Breast Cancer Cell; C-Type Lectins; Cancer cell line; Cell Line; Cells; Communicable Diseases; Complex; Dendritic Cells; Environment; Event; Family; Goals; Hematopoietic; Human; ITAM; Immune; Immune response; Immunoglobulins; Infiltration; Inflammation; Interferon Type I; Interferons; Ligands; Ligation; Malignant Neoplasms; Mammals; Maps; Mediating; Molecular; Molecular Target; Orphan; Pathway interactions; Physiological; Play; Population; Production; Receptor Activation; Receptor Signaling; Receptors, Antigen, B-Cell; Reporter; Research; Role; Signal Pathway; Signal Transduction; Stimulus; Surface; System; T-Cell Receptor; Testing; Therapeutic; Tissues; Toll-like receptors; Transcript; Virus; adaptive immunity; base; carbohydrate structure; cytokine; extracellular; microbial; prototype; receptor; response

DESCRIPTION (provided by applicant): Plasmacytoid dendritic cells (pDCs) represent a specialized immune cell population that produces large amounts of type I interferons (IFN) in response to viruses and function as a critical linkage between innate and adaptive immunity. Our long-term goal is to study the functions of pDCs pertaining to specific physiological environments or conditions. The central hypothesis is that unique pDC receptors play key roles in the biological functions of pDCs through interactions with their ligands and activating specific intracellular pathways. We based that hypothesis on the observation that 1) human pDC receptor ILT7 activates an ITAM-mediated signaling pathway to inhibit IFN responses by pDCs, 2) the potential ligand of ILT7 is expressed by a group of human breast cancer cell lines, and 3) human pDC receptor BDCA2, a C-type lectin with unknown ligand, potentially utilizes the ITAM-mediated mechanism to regulate pDCs' IFN responses. The specific aims are to: 1) Determine the detailed signaling mechanism of ILT7 in human pDCs and study the underlining mechanism how ITAM-mediated pathway intersects with the Toll-like receptor (TLR)-mediated innate immune responses. 2) Identify the natural ligand of ILT7, which is expressed by human breast cancer cell lines, and study its tissue expression in relation with pDC infiltration. The function of the ligand on pDCs through interaction with ILT7 will be thoroughly elucidated. 3) Determine the detailed signaling mechanism used by BDCA2. The natural ligand for BDCA2 is to be screened using a reporter cell system capable of sensing surface BDCA2 engagement. A wide range of carbohydrate structures, microbial agents and cell-associated factors will be tested in this aim. The altered presence and functions of pDCs have been implicated in human ailments such as autoimmune diseases, infectious diseases and cancer. By focusing on the two surface receptors uniquely expressed by human pDCs through pursuing their ligands and shared intracellular signaling mechanism, the proposed studies will greatly advance research on the physiological functions of pDCs and may generate direct molecular targets with therapeutic potential.

描述（由申请人提供）：浆细胞样树突状细胞（pDCs）是一种特殊的免疫细胞群，在对病毒的反应中产生大量的I型干扰素（IFN），并作为先天免疫和适应性免疫之间的关键联系。我们的长期目标是研究pDCs在特定生理环境或条件下的功能。核心假设是，独特的pDC受体通过与其配体的相互作用和激活特定的细胞内通路，在pDC的生物学功能中发挥关键作用。我们基于以下观察得出这一假设：1)人pDC受体ILT7激活itam介导的信号通路抑制pDC对IFN的反应；2)ILT7的潜在配体在一组人乳腺癌细胞系中表达；3)人pDC受体BDCA2是一种配体未知的c型凝集素，可能利用itam介导的机制调节pDC对IFN的反应。具体目的是：1)确定人pDCs中ILT7的详细信号传导机制，研究itam介导的通路与toll样受体（TLR）介导的先天免疫应答交叉的重要机制。2)鉴定人乳腺癌细胞系表达的ILT7天然配体，研究其组织表达与pDC浸润的关系。该配体通过与ILT7的相互作用在pDCs上的功能将被彻底阐明。3)确定BDCA2使用的详细信号机制。BDCA2的天然配体将使用能够感知表面BDCA2接合的报告细胞系统进行筛选。广泛的碳水化合物结构，微生物剂和细胞相关因子将在此目的进行测试。pDCs的存在和功能的改变与自身免疫性疾病、传染病和癌症等人类疾病有关。通过探究pDCs的配体和共享的细胞内信号传导机制，关注人类pDCs独特表达的两种表面受体，将极大地推进对pDCs生理功能的研究，并可能产生具有治疗潜力的直接分子靶点。